Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins β1 and β2
- 15 July 2005
- journal article
- Published by Elsevier BV in Developmental Biology
- Vol. 283 (2), 459-471
- https://doi.org/10.1016/j.ydbio.2005.05.004
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- ADAMs: key components in EGFR signalling and developmentNature Reviews Molecular Cell Biology, 2005
- Selective Roles for Tumor Necrosis Factor α-converting Enzyme/ADAM17 in the Shedding of the Epidermal Growth Factor Receptor Ligand FamilyJournal of Biological Chemistry, 2004
- Potential Role for ADAM15 in Pathological Neovascularization in MiceMolecular and Cellular Biology, 2003
- Catalytic Properties of ADAM19Published by Elsevier BV ,2003
- Neuregulins: functions, forms, and signaling strategiesExperimental Cell Research, 2003
- EGF receptor ligandsExperimental Cell Research, 2003
- Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart functionProceedings of the National Academy of Sciences, 2003
- The incidence of congenital heart diseaseJournal of the American College of Cardiology, 2002
- Cloning and Initial Characterization of Mouse Meltrin β and Analysis of the Expression of Four MetalloproteaseDisintegrins in Bone CellsPublished by Elsevier BV ,1998
- Genetic Disorders of Cardiac MorphogenesisCirculation Research, 1997